Peripheral CHI3L1 expression was elevated in individuals with early-onset AD (EOAD), particularly among APOE ε4 carriers (EOAD APOE ε4+, n = 13 vs. EOAD APOE ε4-, n = 8; p = 0.026). This evidence concerns the gene CHI3L1 and Alzheimer disease.